Opportunities and obstacles for the melanoma immunotherapy using T cell and chimeric antigen receptor T (CAR-T) applications: a literature review-Reference-Cited by-同舟云学术

Opportunities and obstacles for the melanoma immunotherapy using T cell and chimeric antigen receptor T (CAR-T) applications: a literature review

Published:2022-06-18 Issue:11 Volume:49 Page:10627-10633
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Bahmanyar Maryam,Vakil Mohammad Kazem,Al-Awsi Ghaidaa Raheem Lateef,Kouhpayeh Seyed Amin,Mansoori Hosein,Mansoori Yaser,Salahi Afsaneh,Nikfar Ghasem,Tavassoli Alireza,Behmard Esmaeil,Moravej Ali,Ghasemian Abdolmajid^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11033-022-07633-5.pdf

Reference59 articles.

1. Lugowska I, Teterycz P, Rutkowski P (2018) Immunotherapy of melanoma. Contempor Oncol 22(1A):61

2. Weiss SA, Wolchok JD, Sznol M (2019) Immunotherapy of melanoma: facts and hopes. Clin Cancer Res 25(17):5191–5201

3. Franklin C, Livingstone E, Roesch A, Schilling B, Schadendorf D (2017) Immunotherapy in melanoma: recent advances and future directions. Europ J Surg Oncol 43(3):604–611

4. Redman JM, Gibney GT, Atkins MB (2016) Advances in immunotherapy for melanoma. BMC Med 14(1):1–1

5. Achkar T, Tarhini AA (2017) The use of immunotherapy in the treatment of melanoma. J Hematol Oncol 10(1):1–9

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastasiertes Melanom: Neue Kombinationstherapien und Studienansätze;Trillium Krebsmedizin;2024-06-04

2. STING pathway as a cancer immunotherapy: Progress and challenges in activating anti-tumor immunity;Molecular Biology Reports;2024-04-05

3. Cost-utility analysis of Pembrolizumab compared to other alternative immunotherapy and chemotherapy treatments for patients with advanced melanoma in Iran;Expert Review of Pharmacoeconomics & Outcomes Research;2023-09-27

4. Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care;Pigment Cell & Melanoma Research;2023-08-25

5. Metallic Nanoparticles: Their Potential Role in Breast Cancer Immunotherapy via Trained Immunity Provocation;Biomedicines;2023-04-23